Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

511 results about "Quinoxaline" patented technology

A quinoxaline, also called a benzopyrazine, in organic chemistry, is a heterocyclic compound containing a ring complex made up of a benzene ring and a pyrazine ring. It is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. It is a colorless oil that melts just above room temperature. Although quinoxaline itself is mainly of academic interest, quinoxaline derivatives are used as dyes, pharmaceuticals, and antibiotics such as olaquindox, carbadox, echinomycin, levomycin and actinoleutin.

Fluoroquinoxalinone derivatives that selectively inhibit PARP1

The present invention discloses a series of fluorine-substituted heterocyclic compounds, specifically, compounds represented by formula (XII) and pharmaceutically acceptable salts thereof. 【Chemical 1】 JPEG2025516367000403.jpg44170
Owner:サイブランチ セラピューティクス カンパニー リミテッド

Quinoxaline derived sulfonamides with EGFR degradation activities and their uses thereof

PCT designated stage expiredWO2024259216A1Organic active ingredientsOrganic chemistryQuinoxalineDisease
The present disclosure relates to at least one entity chosen from a compound of Formula (I), tautomers, stereoisomers or a mixture of stereoisomers, hydrates, and deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing, and their use as epidermal growth factor receptor (EGFR) degraders for the prevention and treatment of diseases and conditions, e.g., cancer. The present disclosure also relates to pharmaceutical compositions containing such entities, and their use in treating or preventing a disease or disorder associated with EGFR.
Owner:ACCUTAR BIOTECHNOLOGY INC

PARP1 selective protein degradation agent and application thereof in tumor resistance

The invention discloses a PARP1 selective protein degradation agent and an application of the PARP1 selective protein degradation agent in tumor resistance. The degradation agent has the following structural formula. Wherein the 3-ethyl-7-((4-(pyridine-3-yl) piperazine-1-yl) methyl) quinoxaline-2 (1H)-ketone part is a PARP1 target protein ligand, and L is a connecting unit; and B is an E3 ubiquitin ligase ligand. The PARP1 selective protein degradation agent prepared by the preparation method disclosed by the invention can be used for effectively degrading PARP1 protein, inhibiting cell proliferation and inducing tumor cell apoptosis. Meanwhile, when the compound is combined with chemotherapeutic drugs, the effect of enhancing the chemotherapeutic effect is achieved, almost no physiological toxicity exists, and the compound is expected to provide an ideal way for improving treatment of various diseases caused by PARP1 excessive activation. # imgabs0 #
Owner:HANGZHOU SOTO BIOMEDICAL TECHNOLOGY CO LTD

Parkinson's disease specific plasma metabolism marker and application thereof

The invention belongs to the technical field of biomedicine, and discloses a Parkinson's disease specific plasma metabolism marker and application thereof.The plasma metabolism marker comprises uracil, kynurenine, phenolsulfonic acid, p-cresol, di-high gamma-linolenic acid, atorvastatin, 2-methoxybenzoic acid, carabicycline, nitrogen hydroxyl 2-amino-3, 5-di-tert-butyl-3, 5-di-tert-butyl-3, 5-di-tert-butyl-3, 5-di-tert-butyl-3, 5-di-tert-butyl-3, 5- The invention relates to an anti-inflammatory agent which is prepared from 2, 8-dimethylimidazo quinoxaline, dihydroxy phenethyl alcohol O-sulfate, racemization-4-hydroxy-4-O-(beta-D-glucuronate)-all-trans retinol acetate, fructosyl valine, thiaxanthene and acetylpyridine methanol. It is proved for the first time that the 14 plasma metabolites are associated with the Parkinson's disease, a Parkinson's disease prediction method is constructed based on the markers, the prediction result is reliable, and a new way is provided for diagnosis of the Parkinson's disease.
Owner:襄阳市第一人民医院 +1

Organic carbonyl compound electrode material, preparation method and application of organic carbonyl compound electrode material in lithium ion battery

The invention discloses an organic carbonyl compound electrode material, a preparation method and application of the organic carbonyl compound electrode material in a lithium ion battery, and the organic carbonyl compound electrode material is bipyridino [3 ', 2': 5, 6; the invention relates to an organic carbonyl compound electrode material, which is prepared from 2, 2 ', 3': 7, 8] quinoxaline [2, 3-i] bipyridino [3, 2-a: 2 ', 3'-c] phenazine-10, 21-diquinone and 1, 2, 4, 5-tetraamino p-benzoquinone and 1, 10-phenanthroline-5, 6-diketone through a dehydration condensation reaction. When the organic electrode material is used as a positive electrode material to be applied to a lithium ion battery, due to the fact that the organic electrode material contains a large conjugated system, the organic electrode material has good dissolution inertness in electrolyte and is beneficial to electron transmission, and therefore the cycling stability and the rate performance of the battery are improved. In addition, multiple active sites provide more redox active sites to coordinate with lithium ions, so that reversible lithium storage is realized, and relatively high capacity is shown.
Owner:HUNAN UNIV

Light conversion adhesive film based on quinoxaline system light conversion material

The invention provides a light conversion adhesive film for sunlight wavelength conversion and application thereof, the light conversion adhesive film comprises an organic compound # imgabs0 # and a substrate transparent to visible light, the definition of each group in the organic compound is described in the specification, and the mass fraction of the organic compound in the light conversion adhesive film is 0.01%-5%. The light conversion adhesive film can be used for a solar cell so as to enhance the efficiency and the stability of the cell.
Owner:TRINA SOLAR CO LTD

Hole transport material, preparation method thereof and perovskite solar cell

The invention discloses a hole transport material, a preparation method thereof and a perovskite solar cell, and belongs to the technical field of photovoltaic solar materials. The molecular structural formula of the compound is shown as a formula (I) or a formula (II). According to the invention, a quinoxaline part is used as an electron acceptor for extended conjugate modification, a plurality of single donors such as triphenylamine electron donating groups, dihydroacenaphthene, binaphthyloxy and the like are introduced, the hole transport material with a multi-donor structure is constructed, and the hole transport material adjusts the distribution of HOMO-LUMO, increases charge transfer channels, improves the separation and transport capabilities of charges, and improves the hole transport efficiency. Therefore, the mobility of current carriers is improved. A tert-butyl unit is further introduced to the periphery of the triphenylamine group, the hydrophobic property of tert-butyl reduces the interface energy barrier between the hole transport layer and the perovskite precursor solution, directional growth and defect passivation of perovskite crystals are promoted, and the crystallization quality of the perovskite thin film and the device performance are improved.
Owner:GUANGDONG UNIV OF TECH

Star-shaped trimer type non-fullerene acceptor material as well as preparation and application thereof

The invention discloses a star-shaped tripolymer type non-fullerene acceptor material as well as preparation and application thereof. The star-shaped tripolymer type non-fullerene acceptor material has a structure as shown in the following formula: # imgabs0 #. According to the invention, a star-shaped trimer type oligomer material connected with a quinoxaline development center with a derivative site in the middle is adopted, so that the defect that the PCE of the current oligomer type acceptor material is influenced due to oligomerization based on a halogen substitution site of tail-end isatin is overcome; compared with a traditional small molecule material (oligomer type acceptor material), the material has higher open-circuit voltage (Voc), the photoelectric conversion efficiency is excellent, the illumination stability is good, and when the material is applied to a solar cell, the photoelectric conversion efficiency and stability of the cell can be remarkably improved.
Owner:SHANGHAI ZHUYANG NEW ENERGY TECHNOLOGY CO LTD

Process for selective catalytic hydrogenation of dienones

The present disclosure provides a catalyst system capable of selectively hydrogenating (2, 3) / (4, 5) and (2, 3) / (5, 6) dienones with hydrogen. In particular, the present disclosure provides catalysts capable of providing high selectivity for reduction even in the absence of catalyst poisons such as pyridine, pyrazine, quinoline, and quinoxaline.
Owner:BASF SE +1

Preparation method and device of quinoxaline compound

The invention provides a preparation method and device of quinoxaline compounds, and belongs to the technical field of quinoxaline compound synthesis. The preparation method of the quinoxaline compound comprises the following steps: mixing a substituted 1, 2-dicarbonyl compound and a substituted o-phenylenediamine compound to obtain a mixed raw material; and blowing the mixed raw material into a reaction chamber for reaction to obtain the quinoxaline compound, and finally, carrying out vacuum drying on the quinoxaline compound. High-speed spiral gas is formed in the reaction cavity through high-pressure carrier gas, and the mixed raw materials react in the high-speed spiral gas flow. The preparation process provided by the invention has the advantages of low equipment investment, simple process, high reaction speed, high yield, no need of participation of any solvent and catalyst, environmental friendliness and capability of reducing the production cost.
Owner:SOUTHWEAT UNIV OF SCI & TECH

Phenazine-quinoxaline organic electrode material and application thereof in preparation of aqueous zinc ion battery

The invention provides a phenazine-quinoxaline organic electrode material, and belongs to the technical field of aqueous zinc ion battery electrode materials, and the phenazine-quinoxaline organic electrode material is synthesized from 2, 3-diaminophenazine and 2, 5-dihydroxy-1, 4-benzophenone through a dehydration condensation reaction. The organic electrode material can be used for manufacturing a positive electrode of an aqueous zinc ion battery, and shows relatively high reversible specific capacity, relatively long cycle life, relatively good rate capability and relatively good wide temperature range performance. The invention also provides an application of the phenazine-quinoxaline organic electrode material in preparation of an aqueous zinc ion battery.
Owner:YANGJIANG JIAOTONG ZHUOYUE NEW ENERGY TECHNOLOGY CO LTD

Quinoxalinone derivative targeting poly ADP ribose polymerase and androgen receptor as well as preparation method and application of quinoxalinone derivative

The invention relates to a quinoxalinone derivative targeting poly ADP ribose polymerase and an androgen receptor as well as a preparation method and application of the quinoxalinone derivative. The structural formula of the quinoxalinone derivative is as follows: # imgabs0 #, R1 is one of hydrogen, methoxyl, methyl and halogen, the substituent position of R1 is at least one of 5, 6, 7 and 8 sites of a quinoxalinone ring, and X is a carbon atom or a nitrogen atom. The quinoxalinone derivative provided by the invention can be used as an active photosensitizer, a PARP inhibitor and an androgen receptor antagonist and can induce cell synthesis and death, and the process can improve the oxidation state and oxygen concentration in cells and improve the hypoxic microenvironment in tumors, so that the photodynamic therapy effect is further enhanced, namely, the effect of the quinoxalinone derivative is improved. The PDT therapy and the PARP inhibitor have a synergistic effect.
Owner:WUXI JUEXIN BIOTECHNOLOGY CO LTD

All-organic aqueous zinc ion battery positive electrode material as well as preparation method and application thereof

The invention discloses an all-organic aqueous zinc ion battery positive electrode material and a preparation method and application thereof, and belongs to the technical field of new energy materials and batteries, the positive electrode material is an azacyclo organic matter 5, 5, 12, 12 '-tetrahydro-2, 2'-biquinoxaline [2, 3-b] quinoxaline, and the negative electrode material is an imine and carbonyl organic matter. The nitrogen heterocyclic organic positive electrode loses electrons and is oxidized in the charging process, and the imine and carbonyl organic negative electrodes obtain electrons and are reduced, so that stable charging and discharging cycles can be carried out. According to the all-organic water-based zinc ion battery positive electrode material as well as the preparation method and the application thereof, the organic positive electrode with an adjustable structure and rich elements, the relatively stable imine and carbonyl organic negative electrodes and the environment-friendly and safe water-based electrolyte are adopted, and stable charging and discharging of an all-organic water-based zinc ion battery can be realized.
Owner:SHIHEZI UNIVERSITY

Preparation method of brominated benzhydryl quinoxalinone compound

PendingCN120535468AOrganic chemistryDiphenylmethaneBromodiphenylmethane
The invention provides a preparation method of a brominated benzhydryl quinoxaline ketone compound, which comprises the following step: under the condition of illumination, carrying out coupling reaction on 1-methylquinoxaline ketone and brominated diphenylmethane to obtain the brominated benzhydryl quinoxaline ketone compound. The preparation method of the brominated benzhydryl quinoxaline ketone compound provided by the invention is mild in reaction condition and simple and efficient in step.
Owner:聊城市开发区质谱化学科技中心

3-quinoxalinyl imidazoline thioketone derivative, synthetic method and application

PendingCN121226343AOrganic chemistryCardiovascular disorderQuinoxalineImidazolidinethione
The invention relates to 3-quinoxalinyl imidazoline thioketone derivatives, a synthesis method and application technical contents. The structural general formula of the derivative is formula 1 or formula 2. The invention provides a preparation method of the derivative. The invention proves that the developed 3-quinoxalinyl imidazoline thioketone derivative has an anti-myocardial hypertrophy effect and can be applied to preparation, research and development of anti-myocardial hypertrophy drugs.
Owner:YUNNAN UNIV +1

Quinoxalinone boride with high-efficiency double-state luminescence as well as preparation and application of quinoxalinone boride

The invention discloses a quinoxalinone boride with efficient bi-state luminescence and preparation and application thereof.The material mainly takes a quinoxalinone-BF2 structure as a core, the luminescent material has the advantages that synthesis steps are simple, the preparation method is convenient, the luminescent property is excellent, the efficient bi-state photoluminescence property of a solution state and a solid state is achieved, and the luminescent material is suitable for large-scale production. The biotoxicity is low, the biocompatibility is high, and the long-time cell imaging function is realized. And the probe can become a novel biological probe molecular platform.
Owner:JIANGXI NORMAL UNIV

Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device

An organometallic complex having an emission peak in a long wavelength region (a visible region having a wavelength of 700 nm or greater or a near-infrared region) is provided. The organometallic complex has a structure represented by General Formula (G1), in which a ligand having a quinoxaline skeleton is coordinated to a central metal, and an electron-withdrawing group (e.g., fluorine, a cyano group, a trifluoromethyl group, a trifluoromethylsulfonyl group, or a pentafluorosulfanyl group) is included as a substituent at at least one substitutable position of the benzene ring of the quinoxaline skeleton of the ligand.
Owner:SEMICON ENERGY LAB CO LTD

Preparation and application of indolo-indolo-quinoxaline-phenazine MR-TADF blue-light-emitting material

The invention belongs to the technical field of organic photoelectric materials, and particularly relates to preparation and application of an indolo-indole quinoxaline phenazine MR-TADF blue light material. The material has a rigid large-plane skeleton and is modified by a plurality of chemical sites, and efficient and narrow-spectrum blue light emission of the material can be realized by simply regulating and controlling a peripheral hooking group. The blue-light-doped electroluminescent device prepared by the method has the advantages that the blue-light-doped electroluminescent device prepared by the aid of the method has the advantages that the blue-light-doped electroluminescent device prepared by the aid of the method is high in light emitting efficiency, the thermal decomposition temperature can reach 426.1 DEG C, the blue-light-doped electroluminescent device is excellent in thermal stability, the maximum photoluminescence emission peak in methylbenzene solution is 458 nm, the half-peak width of the blue-light-doped electroluminescent device is 40 nm, the fluorescence quantum efficiency of the blue-light-doped electroluminescent device is 78.2%, the maximum emission peak of the obtained blue-light-doped electroluminescent device is 468 nm, color coordinates of the blue-light-doped electroluminescent device are (0.15 and 0.25), and the corresponding maximum external quantum efficiency The MR-TADF blue light-emitting material with an innovative structure and multiple expandability has an attractive application prospect. # imgabs0 #
Owner:CHANGZHOU UNIV

Fluoroquinoxalinone derivatives capable of selectively inhibiting PARP1

The invention discloses a series of fluorine-substituted heterocyclic compounds, and particularly discloses a compound as shown in a formula (XII) and pharmaceutically acceptable salts thereof. # imgabs0 #
Owner:SCIBRUNCH THERAPEUTICS CO LTD

Substituted imidazoquinoxaline compound and application thereof

The invention provides a substituted imidazo quinoxaline compound and application thereof. In particular, the present invention provides a compound of the following Formula II: wherein A1-A3, B1-B4, and R1-R2 are defined herein, a pharmaceutically acceptable salt or prodrug thereof. The compounds of formula II are kinase inhibitors. Therefore, the compound provided by the invention can be used for treating clinical diseases caused by DDR function deficiency, such as cancer. # imgabs0 #
Owner:IMPACT THERAPEUTICS (SHANGHAI) INC +1

A fluorine-containing electrochromic polymer, its preparation method and application

The present invention provides a fluorine-containing electrochromic polymer, a preparation method thereof and an application thereof. The fluorine-containing electrochromic polymer has a structure shown in Formula I. In the present invention, by introducing fluorine atoms into the electrochromic polymer and through the interaction between the fluorine atoms and a single alkoxy group with a specific structure on the quinoxaline group, the prepared fluorine-containing electrochromic polymer has excellent properties, and thus the prepared electrochromic device has a lower starting voltage, a lower contrast attenuation rate, a faster response speed and a higher coloring efficiency.
Owner:SUZHOU OPAK DISPLAY TECH CO LTD

Process for the photocatalytic preparation of quinoxaline-2,3-diones

The application belongs to the field of compound synthesis and particularly relates to a photocatalytic preparation method of quinoxaline-2,3-dione compounds, which comprises the following steps: preparing a raw material solution containing quinoxaline-2-ketone, mercaptan, a photocatalyst and acetonitrile, and performing a photocatalytic reaction under light to obtain a quinoxaline-2,3-dione compound product; the mercaptan is C1-C4 alkyl mercaptan, and the -SH is connected to a primary carbon or a secondary carbon. The application adopts a photocatalytic method to perform hydroxylation on the C3 position of quinoxaline-2-ketone, and further controls the combination of the mercaptan and acetonitrile solvent to improve the photocatalytic reaction effect of C3 hydroxylation.
Owner:HUNAN UNIV OF SCI & ENG

Analogs of quinoxaline / quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof

PCT designated stage expiredWO2025117727A1Organic active ingredientsOrganic chemistryQuinoxalineDisease
The disclosure relates to analogs of quinoxaline / quinoline cytotoxic agents, termed"Nupomycins" herein, linker-payloads, and protein-drug conjugates thereof, pharmaceutical compositions comprising same, and methods of treating disease therewith.
Owner:REGENERON PHARMACEUTICALS INC +3

Process for the preparation of a diphenylmethane quinoxaline ketone derivative

ActiveCN120817905BQuinoxalineAlkane
The application discloses a preparation method of a diphenylmethyl quinoxaline ketone derivative, and belongs to the technical field of biological medicines. The structure of the diphenylmethyl quinoxaline ketone derivative is shown in the specification. The application adopts a cross dehydrogenative coupling strategy, realizes quinoxaline ketone 3-alkylation through direct activation of an alkane and accompanying hydrogen atom transfer, and has the advantages of mild reaction conditions, cheap and easily available reagents, and higher efficiency and environmental friendliness. The diphenylmethyl quinoxaline ketone derivative has high-efficiency and broad-spectrum antifungal activity, shows inhibitory effects on a plurality of common plant pathogenic fungi, and can be developed into a product for treating plant fungal infections.
Owner:DONGGUAN EASTERN CENT HOSPITAL

Benzodithiophene polymer donor with simple and stable structure as well as preparation method and application of benzodithiophene polymer donor

The invention belongs to the technical field of organic solar cell materials, and relates to a benzodithiophene polymer donor with a simple and stable structure and a preparation method and application thereof. The invention discloses a benzodithiophene polymer donor PBTQ-X (F / Cl / 2F) with a simple and stable structure, and discloses a preparation method of the benzodithiophene polymer donor PBTQ-X (F / Cl / 2F), and the preparation method comprises the following steps: under the action of a Stille coupling catalyst, carrying out two-stage polymerization on benzodithiophene containing bis (trimethyltin) and a quinoxaline derivative containing a dibromothiophene pi bridge, carrying out two-stage heating reflux reaction, and carrying out post-treatment to obtain the benzodithiophene polymer donor PBTQ-X (F / Cl / 2F). Adding an end-capping reagent for end capping; and finally, settling after passing through methanol, thereby obtaining the product. The benzodithiophene polymer donor with a simple and stable structure can be applied to an active layer of an organic solar cell device, and shows relatively good photovoltaic performance and long-term stability.
Owner:NINGBO INST OF MATERIALS TECH & ENG CHINESE ACAD OF SCI

Nitrogen-containing fused ring compounds and their applications in organic electroluminescent devices

The present invention relates to a nitrogen-containing fused ring compound and its application in an organic electroluminescent device. The structure of the nitrogen-containing fused ring compound is shown in Formula I. In Formula I, X and Y are the same or different and are each independently oxygen or sulfur; Z is oxygen, sulfur or N-R, where R is an alkyl group or an aryl group; R 1 、R 2 、R 3 and R 4 are the same or different and are each independently H, an alkyl group, an aryl group or a heteroaryl group, and R 1 、R 2 、R 3 and R 4 one or more of them are heteroaryl groups having a nitrogen heterocycle, and the nitrogen-containing heterocycle is selected from one or more of a pyrimidine ring, a quinoxaline ring, a quinazoline ring and a triazine ring. When L 3 and L 4 do not exist, R 3 and R 4 are not H; L 1 、L 2 、L 3 and L 4 are the same or different and are each independently selected from non-existence, arylene and heteroarylene. When the compound of the present invention is applied to an organic electroluminescent device, it has a lower driving voltage and a higher device luminous efficiency.
Owner:BEIJING GREEN GUARDEE TECH +1

A polysubstituted indolo[1,2-a]quinoxaline compound, a preparation method and application thereof

This invention discloses a polysubstituted indole[1,2-a]quinoxaline compound, its preparation method, and its applications. The structural formula of the polysubstituted indole[1,2-a]quinoxaline compound of this invention is or , where R 1 Selected from -H or -F, R 2 The compounds are selected from phenyl, 4-methylphenyl, 4-methoxyphenyl, or 4-fluorophenyl. The polysubstituted indole[1,2-a]quinoxaline compounds of this invention have novel structures and significant antitumor activity, making them suitable for the synthesis of anticancer drugs. Furthermore, their preparation methods offer advantages such as readily available and inexpensive catalysts, broad substrate applicability, good functional group tolerance, simple operation, mild reaction conditions, and high step economy, making them suitable for large-scale industrial production and application.
Owner:SOUTH CHINA UNIV OF TECH